The serum fructosamine assay was originally calibrated with I-deoxy-l-morpholino-D-fructose (DMF) in an albumin matrix. I The use of DMF, however, leads to fructosamine results that are markedly influenced by the reaction conditions, such as reaction temperature, pH and the concentration of nitroblue tetrazolium (NBT) used.l This sensitivity to small changes in reaction conditions can be reduced by calibrating the assay with secondary protein-based calibrators, such as the Roche fructosamine calibrator (Roche Products Ltd, Welwyn Garden City, UK). A major problem with the use of secondary calibrators is that they require fructosamine values to be assigned to them prior to sample analysis. In the case of the Roche fructosamine calibrators, this is achieved by a complex procedure involving the use of in vitro glycated polylysine as a primary calibrator, which itself has its glycation assessed by radioactivity measurements and elemental analysis. 3 Assignation of fruetosamine values to secondary calibrators by this method is only practicable in specialized centres.
The principal sites of glycation of serum proteins are EO-amino groups of lysyl residues. 6-Aminohexanoic acid is a pseudo-lysyl molecule, lacking only the a-amino group (which would not normally be available in vivo as a possible glycation site). Therefore, it was reasoned that 6-aminohexanoic acid, glycated in vitro, may be a suitable alternative calibrator for the fructosamine assay. In this study fructosamine assays, calibrated with glycated 6-aminohexanoic acid (GAHA), were compared with assays calibrated with DMF and the Roche fructosamine calibrator in terms of their sensitivity to changes in the reaction temperature, pH and the concentration of NBT used. The glycated derivatives were separated from the resulting reaction mixture by cation exchange chromatography on a column of Dowex 50W-X8 (Sigma Chemical Co., Poole, UK). Those fractions collected from the column which were shown to contain GAHA (by their reaction with NBT) were pooled, concentrated, purified using SEP-PAK CIS cartridges (Waters Associates Instruments Ltd, Watford, UK) and then lyophilized. Stock solutions of 3 mmollL GAHA and DMF for the fructosamine assay were made by dissolving the appropriate amount of material in a 40/0 (w/v) human serum albumin solution (Blood Products Laboratory, Elstree, UK). The Roche fructosamine calibrator was prepared according to the manufacturer's instructions.
The fructosamine assays were performed on a Cobas Bio centrifugal analyser (Roche Products Ltd, Welwyn Garden City, UK) using an adaptation of the original assay. I The effects of small changes in reaction conditions upon fructosamine assays calibrated with DMF, GAHA and the Roche fructosamine calibrator were investigated using two midmorning serum samples, one from a nondiabetic and the other from a diabetic. A particular temperature (37 c C) , pH (10' 35) and NBT concentration (0' 35 mmollL) were defined as 'standard' for the fructosamine reaction and the assay was performed with each calibrator varying one reaction condition at a time.
The per cent standard value is defined as the mean result of the two samples expressed as a percentage of the result obtained using the 'standard' conditions with each of the calibrators. The results confirm the work of others that fructosamine assays calibrated with DMF are extremely sensitive to small changes in the reaction conditions, such as temperature and pH (see Fig. la and b) GAHA gave relatively stable values over the same range of pH and temperature. These similarities in the performance characteristics of the assays calibrated with GAHA and the Roche calibrator may be due to the similarity of their glycation chemistry. In each case the s-amino group has been glycated. In contrast, DMF is a glycated secondary amine of the heterocyclic compound, morpholine, and as a consequence has different physicochemical properties (see Fig. 2 ). Figure Ic shows that the results with all three calibrators are only slightly affected by changes in NBT concentration. Those assays calibrated with GAHA and DMF show a tendency to decrease as the NBT concentration is increased, whereas the Roche calibrator exhibits a trend in the opposite direction. This contrast may be due to differences in the assay matrix: GAHA and DMF being easily defined, single chemical entities, whereas the Roche calibrator is a stabilized solution of in vitro glycated human serum which may produce complex interactions with NBT.
This work demonstrates that GAHA is a more suitable calibrator of the serum fructosamine assay than DMF. GAHA has the additional advantage of a clearly defined molecular weight and therefore, unlike the Roche calibrator, may be used as a primary calibrator of the assay.
